e-learning
resources
Madrid 2019
Monday, 30.09.2019
Damage and remodelling in pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2019 - Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice
D. Leitz (Heidelberg, Germany), P. Konietzke (Heidelberg, Germany), M. Wielpütz (Heidelberg, Germany), M. Beers (Philadelphia, United States of America), M. Mall (Berlin, Germany), J. Duerr (Berlin, Germany), S. Fraumann (Heidelberg, Germany)
Source:
International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Session:
Damage and remodelling in pulmonary fibrosis
Session type:
Oral Presentation
Number:
2111
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Leitz (Heidelberg, Germany), P. Konietzke (Heidelberg, Germany), M. Wielpütz (Heidelberg, Germany), M. Beers (Philadelphia, United States of America), M. Mall (Berlin, Germany), J. Duerr (Berlin, Germany), S. Fraumann (Heidelberg, Germany). LSC - 2019 - Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice. 2111
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019
Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Ageing Smad3 KO mice develop emphysema and are resistant to Transforming growth factor-β1 (TGF-β1) mediated pulmonary fibrosis
Source: Annual Congress 2003 - Animal models of lung injury: useful or not?
Year: 2003
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Evaluation of
MRP1-5
gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003
Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018
LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Tenascin C knockout mice have an altered lung function at newborn and adult age
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017
Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles
Source: Eur Respir J 2004; 24 : 798-804
Year: 2004
Pseudomonas aeruginosa
(Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF)
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
LSC - 2018 - Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Enhanced lung fibrosis in protein C inhibitor transgenic mice
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004
LSC - 2020 - Glutathione-S-transferase P promotes Interleukin-1ß-induced inflammation and metabolic reprogramming in mice with allergic airways disease
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept